Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY.MX) Q2 2017 Earnings

5MayConfirmed

Q3 2016

Q4 2016

Q1 2017

Q2 2017

-28.06

-25.31

-22.57

-19.83

Details

Expected EPS

-23.8906206

Actual EPS

-23.701012499999997

Surprise EPS

0.19

Surprise Percent

+0.79%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -23.701012499999997 per share for Q2 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.